Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Medtech's US Innovation Hub Aims To Accentuate The Positive In Post-Brexit Phase

Executive Summary

With Brexit moving ever closer, the UK medtech industry is trying to ensure that local manufacturers have a range of commercial options in overseas markets in the post-EU phase. The ABHI is playing a strong support role in this area, following up its recent international growth plan with a new US innovation hub, designed to offer outward-looking UK medtechs the tools to build positions in the world's largest market.


Related Content

UK Medtech Upscales International Plans Ahead of Brexit
UK Medtech Rises Up To Meet The Challenges Of Brexit





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts